Exploring the Prevalence of Antimicrobial Resistance in Salmonella and commensal Escherichia coli from Non-Traditional Companion Animals: A Pilot Study. 2024

Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
Departamento de Producción y Sanidad Animal, Salud Pública Veterinaria y Ciencia y Tecnología de los Alimentos, Facultad de Veterinaria, Instituto de Ciencias Biomédicas, Universidad Cardenal Herrera-CEU, CEU Universities, Calle Santiago Ramón y Cajal 20, 46115 Alfara del Patriarca, Valencia, Spain.

Companion animal ownership has evolved to new exotic animals, including small mammals, posing a new public health challenge, especially due to the ability of some of these new species to harbour zoonotic bacteria, such as Salmonella, and spread their antimicrobial resistances (AMR) to other bacteria through the environment they share. Therefore, the objective of the present pilot study was to evaluate the current epidemiological AMR situation in commensal Escherichia coli and Salmonella spp., in non-traditional companion animal small mammals in the Valencia region. For this purpose, 72 rectal swabs of nine different species of small mammals were taken to assess the antimicrobial susceptibility against 28 antibiotics. A total of one Salmonella enterica serovar Telelkebir 13,23:d:e,n,z15 and twenty commensal E. coli strains were isolated. For E. coli strains, a high prevalence of AMR (85%) and MDR (82.6%) was observed, although neither of them had access outside the household. The highest AMR were observed in quinolones, one of the highest priority critically important antimicrobials (HPCIAs) in human medicine. However, no AMR were found for Salmonella. In conclusion, the results showed that small mammals' commensal E. coli poses a public health risk due to the high AMR found, and the ability of this bacterium to transmit its resistance genes to other bacteria. For this reason, this pilot study highlighted the need to establish programmes to control AMR trends in the growing population of new companion animals, as they could disseminate AMR to humans and animals through their shared environment.

UI MeSH Term Description Entries

Related Publications

Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
January 2013, Frontiers in microbiology,
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
October 2020, Veterinary world,
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
April 2020, Microbial drug resistance (Larchmont, N.Y.),
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
November 2017, Veterinary microbiology,
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
November 2010, Veterinary microbiology,
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
May 2021, Zoonoses and public health,
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
June 2015, Microbial drug resistance (Larchmont, N.Y.),
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
September 2015, Zoonoses and public health,
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
November 2020, Antibiotics (Basel, Switzerland),
Ana Marco-Fuertes, and Santiago Vega, and José Villora-Gonzalez, and Clara Marin, and Laura Montoro-Dasi
November 2025, The Journal of veterinary medical science,
Copied contents to your clipboard!